

"Advanced Clinical AI that transforms health data into proactive care decisions"
Bering develops clinical decision support systems powered by artificial intelligence across the continuum of health and care. The company creates products for population health management, medical imaging triage, and precision medicine that enable clinical teams to deliver proactive care. Its products include Brave AI for risk stratification, BraveCX for chest X-ray analysis with FDA clearance, and Brave NGT for detecting nasogastric tube malposition. Founded in 2010, Bering adopts a user-driven co-design process that builds shared ownership with clinical end users. The company partners with academic institutions worldwide to advance machine learning research, examine AI ethics, and translate innovation into practical tools.


8
Team Members
2010
Founded
Digital Health
Sector
Hybrid
Work Environment
A world where artificial intelligence empowers every clinical team and patient to make better health decisions through proactive, data-driven care that prevents crises before they happen.
At Bering, our mission is to discover and create powerful technologies and bring them to people that need them the most.